Psyence Biomedical Ltd.
Psyence Biomedical Ltd. (PBM) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
pbm · pe ratio · data through Mar 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Psyence Biomedical Ltd. (PBM) measures how much investors pay for each dollar of the company's trailing earnings. PBM's current PE ratio of 2.02x is calculated by dividing its stock price of $3.60 by its TTM earnings per share of $1.78. −85.7% discount vs 5Y avg 14.2x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-03-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Psyence Biomedical Ltd.You PBM | $0M | 2.02x | — | $1.78 |
 Azitra, Inc. AZTR | $2M | N/A | — | -$2.25 |
 Dermata Therapeutics, Inc. DRMA | $1M | N/A | — | -$8.16 |
 PMGC Holdings Inc. ELAB | $3M | N/A | — | -$378.74 |
 GT Biopharma, Inc. GTBP | $5M | N/A | — | -$5.14 |
 Indaptus Therapeutics, Inc. INDP | $4M | N/A | — | -$21.58 |
 Lipella Pharmaceuticals Inc. LIPO | $0M | N/A | — | -$4.79 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-03-31Latest FY2025 | 14.15x | $1.78 | — | |
2024-03-31 FY2024 | — | $-7.85 | — | |
2023-03-31 FY2023 | — | $0.25 | +11.0% | |
2022-03-31 FY2022 | — | $0.25 | — | |
2021-03-31 FY2021 | — | $0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Psyence Biomedical Ltd. (PBM) measures how much investors pay for each dollar of the company's trailing earnings. PBM's current PE ratio of 2.02x is calculated by dividing its stock price of $3.60 by its TTM earnings per share of $1.78.
Frequently asked questions
PBM pe ratio · 6 questionsPBM's current PE ratio is 2.02x as of 2026-06-08, based on a stock price of $3.60 and TTM EPS of $1.78. Data sourced from Financial Modeling Prep via PBM's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Psyence Biomedical Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08